Danielle Antalffy

Work

Analyst Danielle Antalffy works at UBS and is focused on Healthcare, Technology sectors with 593 price targets and ratings documented since 2008 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 64.91% with an average time for price targets to be met of 238.92 days.

Most recent stock forecast was given on JNJ, Johnson & Johnson at 20-Jul-2022.

Danielle Antalffy best performing recommendations are on SWAV (SHOCKWAVE MEDICAL, INC).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 12/1/2014. The price target of $35 was fulfilled within 4 days with a profit of $6.15 (21.32%) receiving and performance score of 53.29.

Average potential price target upside

ABMD ABT BSX DXCM EW INGN JNJ MDT NVRO PODD TNDM CSII VCEL ATRC AXNX BAX INSP NARI SENS SILK SWAV TMCI UTRS VCRA LNTH ZBH

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

388

$6.98 (1.83%)

355

2 months 27 days ago

1/4 (25%)

$72.29 (24.78%)

103

Sell

380

$-1.02 (-0.27%)

235

2 months 27 days ago

5/6 (83.33%)

$-35.88 (-11.57%)

225

Buy

380

$-1.02 (-0.27%)

350

2 months 28 days ago

25/40 (62.5%)

$71.16 (27.20%)

141

Buy

300

$-81.02 (-21.26%)

145

3 months 16 days ago

7/7 (100%)

$13.69 (15.69%)

89

Sell

235

$-146.02 (-38.32%)

275

6 months 14 days ago

15/20 (75%)

$4.31 (1.14%)

236

Show more analysts
ABMD ABT BSX DXCM EW INGN JNJ MDT NVRO PODD TNDM CSII VCEL ATRC AXNX BAX INSP NARI SENS SILK SWAV TMCI UTRS VCRA LNTH ZBH